Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) rose 1.2% during trading on Friday . The stock traded as high as $4.18 and last traded at $4.18. Approximately 9,282 shares were traded during trading, a decline of 94% from the average daily volume of 152,588 shares. The stock had previously closed at $4.13.
Wall Street Analyst Weigh In
CLBT has been the subject of several analyst reports. Needham & Company LLC upped their target price on Cellebrite DI from $6.00 to $6.50 and gave the company a "buy" rating in a report on Thursday, August 11th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. Cowen reduced their price objective on Cellebrite DI from $13.00 to $10.00 and set an "outperform" rating for the company in a research note on Friday, August 12th. William Blair downgraded Cellebrite DI from an "outperform" rating to a "market perform" rating in a research note on Friday, August 12th. Finally, Bank of America downgraded Cellebrite DI from a "buy" rating to a "neutral" rating and reduced their price objective for the stock from $6.50 to $6.00 in a research note on Friday, August 12th. Two analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average target price of $9.71.
Get Cellebrite DI alerts:Cellebrite DI Price Performance
The stock has a market cap of $810.72 million, a price-to-earnings ratio of 5.81, a P/E/G ratio of 9.78 and a beta of 0.87. The business has a fifty day moving average of $5.00 and a 200 day moving average of $5.33.
Institutional Trading of Cellebrite DI
Several large investors have recently added to or reduced their stakes in CLBT. Phoenix Holdings Ltd. grew its position in Cellebrite DI by 303.6% in the first quarter. Phoenix Holdings Ltd. now owns 2,296,345 shares of the company's stock worth $14,706,000 after acquiring an additional 1,727,379 shares in the last quarter. Greenhaven Road Investment Management L.P. bought a new stake in Cellebrite DI in the fourth quarter worth approximately $9,453,000. Blair William & Co. IL grew its position in Cellebrite DI by 3,021.1% in the first quarter. Blair William & Co. IL now owns 523,978 shares of the company's stock worth $3,353,000 after acquiring an additional 507,190 shares in the last quarter. ARK Investment Management LLC bought a new stake in Cellebrite DI in the first quarter worth approximately $2,621,000. Finally, CIBC Asset Management Inc grew its position in Cellebrite DI by 5.8% in the first quarter. CIBC Asset Management Inc now owns 2,352,733 shares of the company's stock worth $15,057,000 after acquiring an additional 129,244 shares in the last quarter. 20.41% of the stock is owned by institutional investors.About Cellebrite DI
(Get Rating)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Read More
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- Will Wall Street's Enthusiasm About Datadog Lead To Big Gains?
- MarketBeat: Week in Review 9/19 – 9/23
- Why Does Tesla Stock Remain Resilient?
- 2 Semiconductor Stocks To Watch For Reversals
- Are Layoffs At A Small-Cap Tech A Bellwether For Housing Stocks?
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.